Zobrazeno 1 - 5
of 5
pro vyhledávání: '"J. N. Khantakova"'
Autor:
M. S. Kuznetsova, J. A. Shevchenko, J. N. Khantakova, A. A. Khristin, I. A. Obleukhova, A. N. Silkov, S. V. Sidorov, S. V. Sennikov
Publikováno v:
Медицинская иммунология, Vol 23, Iss 4, Pp 785-790 (2021)
The NF-κB transcription factor controls the expression of genes responsible for cell cycle, apoptosis, and other immunoregulatory functions. Some nonspecific NF-κB inhibitors were found after discovering the possibility of blocking tumor growth thr
Externí odkaz:
https://doaj.org/article/665db60d517d4864b608bc5c4ed8e1ce
Publikováno v:
Бюллетень сибирской медицины, Vol 17, Iss 1, Pp 199-210 (2018)
The intensive study of the cellular approaches for the correction of different pathologies, including immunopathological processes and oncology, as well as the investigation of the immunosuppressive role of the regulatory T-cells (Tregs) made conditi
Externí odkaz:
https://doaj.org/article/7d7cf94fc10f4a62aa4d9ad89a3a3510
Autor:
I. A. Obleukhova, J. A. Shevchenko, S V Sidorov, Sergey V. Sennikov, A. A. Khristin, J. N. Khantakova, M. S. Kuznetsova, A. N. Silkov
Publikováno v:
Medicinskaâ Immunologiâ, Vol 23, Iss 4, Pp 785-790 (2021)
The NF-κB transcription factor controls the expression of genes responsible for cell cycle, apoptosis, and other immunoregulatory functions. Some nonspecific NF-κB inhibitors were found after discovering the possibility of blocking tumor growth thr
Autor:
J. A. Shevchenko, M. S. Kuznetsova, J. N. Khantakova, S V Sidorov, V.P. Tereschenko, S.V. Sennikov, A. A. Khristin
Publikováno v:
Annals of Oncology. 31:S1112
Autor:
S.A. Falaleeva, J. A. Lopatnikova, I. A. Obleukhova, V. V. Kozlov, A. A. Khristin, J. N. Khantakova, A. V. Sokolov, N. A. Kiryishina, V. V. Kurilin, A. P. Cherkasov, E. V. Kulikova, J. A. Shevchenko, S V Sidorov, A. E. Vitsin, Sergey V. Sennikov
Publikováno v:
Proceedings of the Scientific-Practical Conference "Research and Development-2016" ISBN: 9783319628691
Currently, one of the most promising approaches for the treatment of oncological patients is the selective activation of T-cell antitumor immunity using immune cells. The generation of functionally active DCs in vitro constitutes a promising approach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9177e97e22e8d7000e9034ff149b2ab
https://doi.org/10.1007/978-3-319-62870-7_56
https://doi.org/10.1007/978-3-319-62870-7_56